ProMIS Neurosciences to Present at the 2022 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PDTM) and Related Neurological Disorders

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it will be presenting at the upcoming AD/PDTM International Conference, to be held in Barcelona Spain, March 15-20, 2022.      Optimizing vaccine […]

Continue Reading

Skyharbour’s Partner Company Basin Uranium Corp. Provides Permitting Update at Mann Lake Uranium Project

Skyharbour Resources Ltd.’s (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) partner company, Basin Uranium Corp. (“Basin Uranium”), is pleased to provide an update on ongoing permitting for an extensive exploration and drilling program at the Mann Lake uranium project in Saskatchewan’s prolific Athabasca Basin. The Mann Lake project is located 25 km southwest of the McArthur River Mine, the largest high-grade […]

Continue Reading

FIRST URANIUM RESOURCES LTD. TO ACQUIRE SOUTHWIND CORPORATION

First Uranium Resources Ltd. (the “Company” or “First Uranium”) (CSE: URNM) is pleased to announce it has entered into a binding letter of intent (the “LOI”) for an option to acquire all of the shares of Southwind Corporation (“Southwind”), a Delaware corporation, holding significant exploration and development properties in and around Independence County, Arkansas, United States […]

Continue Reading
1

NEVGOLD INTERCEPTS 2.13 G/T OXIDE AU OVER 58.2 METERS, INCLUDING 12.32 G/T OXIDE AU OVER 5.9 METERS AT THE CADILLAC VALLEY TARGET AREA AT LIMOUSINE BUTTE

NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQB:NAUFF) (Frankfurt:5E50) is pleased to announce the initial portion of assays from the Company’s first drill hole (CV22-001) at the Cadillac Valley target area at its Limousine Butte Project, Nevada (the “Project”) located on the southern part of the Carlin Trend.   NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) […]

Continue Reading

ProMIS Neurosciences’ PMN310 antibody demonstrates significant cognitive benefit in a mouse model of Alzheimer’s disease

Transgenic mouse model reflects latest scientific understanding of disease – toxic oligomers of amyloid create cognitive deficit…   ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, announced today that PMN310,  its lead antibody therapeutic candidate for Alzheimer’s disease (AD), […]

Continue Reading

Fobi Announces $922,823 In Second Quarter Revenue

Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the “Company” or “Fobi”), a leading data intelligence company using artificial intelligence to help clients turn real-time data into actionable insights and personalized customer engagement is pleased to announce its second quarter (October 1st, 2021 to December 31st, 2021) financial results.   Key Financial and Operational Highlights for Q2:   […]

Continue Reading

Skyharbour’s Partner Company Azincourt Energy Provides Update on Drilling Progress At The East Preston Uranium Project

Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt), is pleased to provide an update on the 2022 exploration program at the East Preston uranium project, located in the western Athabasca Basin, Saskatchewan, Canada.   Project Location – Western Athabasca Basin, Saskatchewan, Canada: https://www.skyharbourltd.com/_resources/maps/Sky_EastPreston_20211209.jpg   Drilling at the East Preston Project commenced on January 24th, and as […]

Continue Reading
Storage and utilization of nuclear radioactive waste concept bac

Skyharbour Intersects Additional High Grade Uranium Mineralization Including 2.07% U3O8 over 4.0m within 19.5m of 0.54% U3O8 at the Moore Uranium Project, Saskatchewan

Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce the results of the final six holes from its 2021 summer/fall diamond drilling program at its 100% owned Moore Uranium Project.   The project comprises 35,705 hectares approximately 15 kilometres east of Denison Mine’s Wheeler River Project, and is proximal to regional infrastructure for Cameco’s […]

Continue Reading
Neurologist scientist researcher analyzing brain activity during neuroscience experiment

ProMIS Neurosciences Appoints Renowned Neuroscientists, Dr. Guy Rouleau and Dr. Alain Dagher to its Scientific Advisory Board

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has appointed Drs. Guy Rouleau and Alain Dagher to its scientific advisory board (SAB).   Dr. Guy Rouleau, MD, PhD, […]

Continue Reading